Nektar Therapeutics (NKTR) Non-Current Assets (2010 - 2026)
Nektar Therapeutics (NKTR) recorded Non-Current Assets of $355.73 million in Q2 2026, compared with $20.97 million a year earlier and up 104.2% from the prior quarter.
Powered by 
Analysis
Nektar Therapeutics (NKTR) Non-Current Assets (2010 - 2026) Analysis & Trends
At the end of FY2025, Nektar Therapeutics reported Non-Current Assets of $14.14 million, down 66.8% from FY2024.
- Annual Non-Current Assets has declined for seven straight years, with a five-year compound annual growth rate of -48.8% (FY2020 to FY2025).
- Across earlier years, Non-Current Assets came in at $42.56 million in FY2024 (-36.8%), $67.33 million in FY2023 (-59.1%), $164.63 million in FY2022 (-48.8%) and $321.61 million in FY2021 (-19.8%).
- The Q2 2026 figure is the highest quarterly Non-Current Assets since Q1 2021.
- On a year-over-year basis, Non-Current Assets rose in 1 of the last seven quarters, with growth averaging 39.9%.
- Peak year-over-year performance for Non-Current Assets in the last five years was growth of 561.8% in Q1 2026, against a decline of 76.2% in Q3 2023 at the low end.
- Per Business Quant, the preceding three quarters came in at $174.23 million (Q1 2026), $14.14 million (Q4 2025) and $19.99 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Nektar Therapeutics | 2.00 Bn | 227.61 Mn | - | 355.73 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 355.73 Mn |
| Mar 31, 2026 | 174.23 Mn |
| Dec 31, 2025 | 14.14 Mn |
| Sep 30, 2025 | 19.99 Mn |
| Jun 30, 2025 | 20.97 Mn |
| Mar 31, 2025 | 26.33 Mn |
| Dec 31, 2024 | 42.56 Mn |
| Sep 30, 2024 | 21.49 Mn |
| Jun 30, 2024 | 48.15 Mn |
| Mar 31, 2024 | 76.18 Mn |
| Dec 31, 2023 | 67.33 Mn |
| Sep 30, 2023 | 43.22 Mn |
| Jun 30, 2023 | 53.22 Mn |
| Mar 31, 2023 | 70.68 Mn |
| Dec 31, 2022 | 164.63 Mn |
| Sep 30, 2022 | 181.52 Mn |
| Jun 30, 2022 | 196.45 Mn |
| Mar 31, 2022 | 290.66 Mn |
| Dec 31, 2021 | 321.61 Mn |
| Sep 30, 2021 | 291.11 Mn |
API Access
Nektar Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=NKTR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "NKTR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=NKTR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();